Structures by: Bari A.
Total: 14
C19H25O8
C19H25O8
Journal of natural products (2017) 80, 6 1900-1908
a=6.4987(3)Å b=6.9114(3)Å c=41.4349(19)Å
α=90.00° β=90.00° γ=90.00°
3-(1-Adamantyl)-1-{[4-(2-methoxyphenyl)piperazin-1-yl]methyl}-4-methyl- 1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C25H35N5OS
Acta Crystallographica Section E (2010) 66, 7 o1756
a=11.0203(2)Å b=12.1148(2)Å c=18.7624(4)Å
α=90.00° β=103.4730(10)° γ=90.00°
(<i>Z</i>)-3-Hydrazinylidene-1-phenylindolin-2-one
C14H11N3O
Acta Crystallographica Section E (2010) 66, 11 o3014
a=19.328(3)Å b=41.612(5)Å c=5.6288(7)Å
α=90.00° β=90.00° γ=90.00°
3-Acetyl-5-methyl-1-(4-methylphenyl)-1<i>H</i>-pyrazole-4-carboxamide
C14H15N3O2
Acta Crystallographica Section E (2010) 66, 11 o3010
a=5.0521(6)Å b=10.4068(13)Å c=12.6558(16)Å
α=103.295(2)° β=95.338(2)° γ=100.072(2)°
<i>N</i>'-[(2-<i>n</i>-Butyl-4-chloro-1<i>H</i>-imidazol-5- yl)methylidene]adamantane-1-carbohydrazide sesquihydrate ethanol hemisolvate
C19H27ClN4O,0.5C2H6O,1.5H2O
Acta Crystallographica Section E (2010) 66, 8 o2131
a=7.9867(6)Å b=16.8478(13)Å c=16.9656(13)Å
α=97.3410(10)° β=100.3760(10)° γ=97.5050(10)°
3,4,7-Trimethyl-2-(4-methylphenyl)-2<i>H</i>-pyrazolo[3,4-<i>d</i>]pyridazin- 5-ium thiocyanate
C15H17N4,CNS
Acta Crystallographica Section E (2010) 66, 12 o3344
a=18.2445(5)Å b=7.3341(2)Å c=24.2396(8)Å
α=90.00° β=106.121(3)° γ=90.00°
4-(3,4-Diacetyl-5-methyl-1<i>H</i>-pyrazol-1-yl)benzenesulfonamide
C14H15N3O4S
Acta Crystallographica Section E (2011) 67, 3 o693
a=8.3716(3)Å b=21.7722(8)Å c=7.8915(3)Å
α=90.00° β=90.00° γ=90.00°
3-[(<i>E</i>)-3-(4-Methoxyphenyl)prop-2-enoyl]-1-(4-methylphenyl)-5- phenyl-1<i>H</i>-pyrazole-4-carbonitrile
C27H21N3O2
Acta Crystallographica Section E (2011) 67, 3 o694
a=10.9995(7)Å b=11.0531(8)Å c=11.4381(8)Å
α=95.113(6)° β=111.582(6)° γ=118.219(7)°
Ethyl 5-bromo-1-benzofuran-2-carboxylate
C11H9BrO3
Acta Crystallographica Section E (2011) 67, 3 o696
a=3.8869(3)Å b=23.780(2)Å c=11.0820(7)Å
α=90.00° β=96.905(8)° γ=90.00°
3-(5-Phenyl-4-phenylsulfonyl-1-<i>p</i>-tolyl-1<i>H</i>-pyrazol-3-yl)- 1,2-dihydroquinoxaline
C30H24N4O2S
Acta Crystallographica Section E (2011) 67, 3 o695
a=6.2829(2)Å b=24.5162(7)Å c=15.9180(5)Å
α=90.00° β=91.925(3)° γ=90.00°
3,3-Diethoxy-5-fluoro-2,3-dihydro-1<i>H</i>-indol-2-one
C12H14FNO3
Acta Crystallographica Section E (2012) 68, 2 o487
a=9.3218(6)Å b=9.4320(5)Å c=14.1544(8)Å
α=100.475(5)° β=104.453(5)° γ=90.238(5)°
<i>rac</i>-2-Amino-1,2-diphenylethanol
C14H15NO
Acta Crystallographica Section E (2012) 68, 2 o491
a=26.6096(6)Å b=5.38690(10)Å c=17.1043(4)Å
α=90.00° β=114.689(3)° γ=90.00°
2-Ethoxy-5-methylbis[1,2,4]triazolo[1,5-<i>a</i>:4',3'-<i>c</i>]quinazoline
C13H12N6O
Acta Crystallographica Section E (2012) 68, 1 o101
a=7.4121(11)Å b=19.240(3)Å c=9.3096(14)Å
α=90.00° β=109.051(2)° γ=90.00°
<i>rac</i>-2-Methylamino-1,2-diphenylethanol
C15H17NO
Acta Crystallographica Section E (2012) 68, 2 o492
a=27.4279(7)Å b=5.69216(11)Å c=17.1910(5)Å
α=90.00° β=116.223(3)° γ=90.00°